Monopar Therapeutics (MNPR) EBT Growth (3y) (2020 - 2025)
Monopar Therapeutics (MNPR) EBT Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -20.99% |
| Jun 30, 2025 | 3.27% |
| Mar 31, 2025 | -9.38% |
| Sep 30, 2024 | 15.65% |
| Jun 30, 2024 | 5.13% |
| Mar 31, 2024 | 3.47% |
| Sep 30, 2023 | -5.84% |
| Jun 30, 2023 | -17.06% |
| Mar 31, 2023 | -29.92% |
| Dec 31, 2022 | -52.38% |
| Sep 30, 2022 | -46.48% |
| Jun 30, 2022 | -44.33% |
| Mar 31, 2022 | -19.85% |
| Dec 31, 2021 | -58.40% |
| Sep 30, 2021 | -53.86% |
| Jun 30, 2021 | -45.26% |
| Mar 31, 2021 | -27.23% |
| Dec 31, 2020 | -62.67% |
| Sep 30, 2020 | 52.00% |
| Jun 30, 2020 | -35.01% |